Repetitive Transcranial Magnetic Stimulation (TMS) for Medication-Resistant Depression
The FDA has cleared a new device for treatment of major depressive disorder (MDD) resistant to antidepressant medication. The NeuroStar TMS System (Neuronetics) produces pulsed magnetic fields that can induce electrical currents in the brain. Unlike electroconvulsive therapy (ECT), it does not require anesthesia or induction of seizures. Other similar devices are under development....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Repetitive Transcranial Magnetic Stimulation (TMS) for Medication-Resistant Depression
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1305
Article Code: 1305c
Date: February 9, 2009
Volume: 51
Pages: 11-12
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1305
Article Code: 1305c
Date: February 9, 2009
Volume: 51
Pages: 11-12
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)